| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655705 | Digestive and Liver Disease | 2017 | 15 Pages |
Abstract
AZA may be efficacious in maintaining clinical response in one-fifth of patients with refractory UP in a real-life setting.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Anne-Laure Mallet, Guillaume Bouguen, Guillaume Conroy, Xavier Roblin, Jean-Bernard Delobel, Jean-François Bretagne, Laurent Siproudhis, Laurent Peyrin-Biroulet,